EP300 and neoplasm: Promotes CBP/p300 degradation and inhibits KAT activity. Inhibits cell proliferation of a wide variety of tumor cells, and sensitizes to radiotherapy and chemotherapy. Affects various signaling pathways in cancer cells independently by its KAT inhibitory activity